
News|Articles|September 1, 2002
Kytril Injection (Granisetron HCl) Hoffmann-La Roche
Serotonin 5-HT3 receptor now indicated for prevention/treatment of PONV
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Challenges & Solutions behind post-acute care models with OneHome's Noel Gilliam
2
Fecal Transplants with Immunotherapy Extend Survival in Advanced Melanoma Patients
3
Study explores growth hormone signaling in bladder cancer
4
DCIS Redefined: Circulating Tumor Cells Prove Early Dissemination and Challenge the 'Preinvasive' Label
5


















































